BUD vs STZ: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: STZ is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BUD and STZ share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BUD and STZ exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Anheuser-Busch InBev SA/NV is the largest beer company in the world, formed through a series of mega-mergers that combined Anheuser-Busch, InBev, and SABMiller. It is headquartered in Leuven, Belgium, and its US-listed shares trade as an American Depositary Receipt (ADR) under the ticker BUD, so US investors own a receipt representing the underlying foreign shares. Its portfolio spans global brands such as Budweiser, Corona, and Stella Artois, alongside Michelob Ultra and a wide set of local champion brands that lead individual markets across Latin America, Africa, and Asia Pacific.

Full BUD guide

Constellation Brands is a producer, marketer, and distributor of beer, wine, and spirits, best known for holding the US rights to Mexican import beers including Corona, Modelo Especial, and Pacifico. Beer is the economic engine: it drives the large majority of both net sales and operating income, and Modelo Especial has been one of the top-selling beer brands in the US. The wine and spirits segment is far smaller and has been contracting, partly by design after the company divested lower-priced wine brands (including SVEDKA and a 2025 wine portfolio sale) to concentrate on higher-margin labels.

Full STZ guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• BUD drivers: Premiumization and pricing power; Deleveraging the balance sheet.
• STZ drivers: Imported beer franchise; Cash generation and buybacks.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The clearest risk is the debt load itself: while falling, it remains large, and slow deleveraging or higher interest rates would keep pressure on the stock. For STZ, the largest risk is US tariffs on Mexican imports: because the bulk of Constellation's beer is brewed in Mexico, tariff changes can meaningfully pressure margins and earnings, and management has flagged a potential multi-dollar per-share EPS headwind.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick BUD if you believe its drivers more; STZ if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BUD and STZ guides.

BUD. Figures are approximate and tied to the asOf date; verify live numbers before acting. For AB InBev, much of the valuation debate centers on the pace of debt reduction rather than on quarterly volume: faster deleveraging is widely seen as the catalyst that could re-rate the shares, while stalled progress or currency headwinds can weigh on them. As an ADR, reported results and any dividend are translated from foreign currencies, so a strong US dollar can dampen returns for US holders independent of how the underlying business performs.

STZ. Figures are approximate and drawn from mid-2026 market data and the company's fiscal 2026 disclosures. The low-teens earnings multiple sits well beneath STZ's multi-year historical range, reflecting tariff and demand concerns. Reported net income can be distorted in periods with large non-cash wine and spirits impairments, so free cash flow is often a cleaner read on the business.

Headline figures (approximate, Jul 2026): BUD shows business model World's largest brewer; sells beer and Beyond Beer at global scale, with growth driven by premiumization, pricing, and emerging-market volume, recent revenue Q1 2026 revenue of roughly $15.3 billion, up about 12% year over year on price and mix rather than large volume gains, recent earnings Q1 2026 adjusted earnings per share reached a record first-quarter level, up sharply from a year earlier, leverage Net-debt-to-EBITDA around 2.9 times at end of 2025, with a stated goal of moving toward roughly 2.0 times over time; STZ shows market cap ~$25B, share price ~$130, p/e (trailing) ~13, fy2026 operating cash flow ~$2.67B.

BUD and STZ are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BUD and STZ exposure against your real portfolio. It is not an investment adviser.